OKKLUSIONSVORRICHTUNG
European patent · EP4011303 · Deleted
Register entry
- Publication number
- EP4011303
- Application number
- EP22154998
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Dec 7, 2016
- Published
- Jun 15, 2022
- Granted
- Jun 12, 2024
- Deleted
- Jul 23, 2025
- Reason
- Annual fee unpaid
- IPC classes
- A61B 17/12 (2006.01)A61B 90/00 (2016.01)
- Priority
- US 201562264171 P 07.12.2015
- Divided from
- EP16808631
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 23, 2025
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.07.2025
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.07.2025
- Apr 23, 2025
Change
Published in Swissreg on 23.04.2025
- Jun 26, 2024
Owner
- Owner
- Cerus Endovascular Limited, John Eccles House, Oxford Science Park, Oxford, Oxfordshire OX4 4GP, United Kingdom → Stryker Ireland Technology Ltd., IDA Business & Technology Park, Carrigtwohill, Co., Cork T45 HX08, Ireland
Published in Swissreg on 26.06.2024
- Jun 12, 2024
Granted
Published in Swissreg on 12.06.2024
Parties
Holder
Inventor
GRIFFIN, Stephen
San Jose, California, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.